Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility Study of New Method of Diagnostic and Prediction of Painful CIPN

NCT03206216 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.

NCT NCT03206216
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03206216 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility Study of New Method of Diagnostic and Prediction of Painful CIPN
Lead sponsor
Stanford University
Phase
Not applicable
Overall status
Terminated
Start date
August 4, 2017
Completion date
October 30, 2017
Enrollment
1 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

burning pain, impaired balance, malignant ovarian neoplasm, numbness, pain, acute, peripheral neuropathy, tingling